跳至主要内容
临床试验/NCT05121415
NCT05121415已完成不适用

Preventive and Personalized Medicine (2021-2023)

Asfendiyarov Kazakh National Medical University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
genotyping for the SNP associated with hemorrhagic stroke complicating severe eclampsia in pregnancy

研究概览

简要总结

To search for a genetic marker of hemorrhagic stroke complicating severe eclampsia, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with hemorrhagic stroke and normal control will be performed.

详细描述

Detailed Description:

Unrelated Korean subjects who have Spontaneous hemorrhagic stroke complicating severe eclampsia in pregnancy were recruited in the current study. Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with hemorrhagic stroke and normal control subjects free of hemorrhagic stroke

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •patients with hemorrhagic stroke complicating severe eclampsia in pregnancy

排除标准

  • •patients without hemorrhagic stroke complicating severe eclampsia in pregnancy

结局指标

主要结局

genotyping for the SNP associated with hemorrhagic stroke complicating severe eclampsia in pregnancy

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Asfendiyarov Kazakh National Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ildar Fakhradiyev

Head of the Laboratory of Experimental Medicine

Asfendiyarov Kazakh National Medical University

研究点 (1)

Loading locations...

相似试验